Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk/science-based approach to validation: a win-win-win for patients, regulators, and industry.

Karen A Welch1, Conrad A Fung, Stephen R Schmidt

  • 1Center for Risk-based Strategies, Inc., Grayslake, IL 60030, USA.

PDA Journal of Pharmaceutical Science and Technology
|April 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individual differences in memory disruption caused by simulated cellphone notifications.

Memory (Hove, England)·2022
Same author

Distinctiveness and priority in free recall of words.

Memory (Hove, England)·2020
Same author

Revisiting von Restorff's early isolation effect.

Memory & cognition·2016
Same author

The emotional carryover effect in memory for words.

Memory (Hove, England)·2016
Same author

Inattentional blindness and the von Restorff effect.

Memory & cognition·2014
Same author

Memory for emotional words in sentences: the importance of emotional contrast.

Cognition & emotion·2012
Same journal

A PAT-aligned framework for installing and operating particle counting systems to detect pre-limit particle-size distribution shifts in ISO-8 (non-sterile) controlled areas.

PDA journal of pharmaceutical science and technology·2026
Same journal

Using Positive Controls to Define the Defect Detection Range for CCIT Method Development and Validation.

PDA journal of pharmaceutical science and technology·2026
Same journal

Patient-Centric Drug Delivery: Establishing Injection Hold Time Limits for Large Volume Autoinjectors.

PDA journal of pharmaceutical science and technology·2026
Same journal

Gas flow through micro-capillaries â which flow law is most suitable to predict the flow rate through micro-capillaries?

PDA journal of pharmaceutical science and technology·2026
Same journal

Peer Review.

PDA journal of pharmaceutical science and technology·2026
Same journal

In-situ Verification of Disinfection Rotation for Contamination Control.

PDA journal of pharmaceutical science and technology·2026
See all related articles

This study introduces a risk-based validation strategy that aligns regulatory compliance with business success. This approach ensures patient safety and reduces healthcare costs, benefiting patients, regulators, and industry.

Area of Science:

  • Pharmaceutical Manufacturing
  • Quality Assurance
  • Regulatory Compliance

Background:

  • The traditional view often pits regulatory compliance against business profitability, leading to superficial adherence to regulations.
  • This disconnect can result in product failures, patient health risks, and increased medication costs, impacting the entire healthcare system.

Purpose of the Study:

  • To propose a novel risk/science-based validation strategy that reconciles regulatory expectations with business objectives.
  • To demonstrate how this strategy can lead to a win-win-win outcome for patients, regulators, and the pharmaceutical industry.

Main Methods:

  • Utilizing design of experiments (DOE) for a science-based validation approach.
  • Aligning with the U.S. Food and Drug Administration's (FDA) Process Analytical Technology (PAT) framework.

Related Experiment Videos

Main Results:

  • Achieving regulatory compliance without compromising business goals.
  • Reducing operational waste and positively impacting the bottom line for businesses.
  • Enhancing product quality and lowering costs for patients.

Conclusions:

  • A science-based validation strategy offers a pathway to simultaneous regulatory compliance and business profitability.
  • This integrated approach minimizes risks for all stakeholders: patients, regulators, and industry.
  • The strategy supports improved patient outcomes through higher quality and lower cost medications.